Eli Lilly Corp. buy Guggenheim
Start price
20.06.25
/
50%
€662.90
Target price
20.06.26
€813.01
Performance (%)
30.64%
Price
26.02.26
€866.00
Summary
This prediction is currently active. With a performance of 30.64% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 20.06.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -0.391% | -0.391% |
| iShares Core DAX® | 1.232% | 1.501% |
| iShares Nasdaq 100 | 0.695% | -1.949% |
| iShares Nikkei 225® | 2.085% | 11.061% |
| iShares S&P 500 | 0.419% | 0.215% |
Comments by Guggenheim for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $936.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Guggenheim for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€881.00
20.01.26
20.01.26
€997.30
20.01.27
20.01.27
-1.70%
26.02.26
26.02.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€710.00
16.10.25
16.10.25
€812.06
16.10.26
16.10.26
21.97%
26.02.26
26.02.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€728.50
08.10.25
08.10.25
€815.37
08.10.26
08.10.26
18.87%
26.02.26
26.02.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€556.70
13.08.25
13.08.25
€749.35
13.08.26
13.08.26
55.56%
26.02.26
26.02.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€672.80
11.07.25
11.07.25
€806.82
11.07.26
11.07.26
28.72%
26.02.26
26.02.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€656.40
14.04.25
14.04.25
€814.97
14.04.26
14.04.26
31.93%
26.02.26
26.02.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€844.20
16.08.24
16.08.24
€935.65
16.08.25
16.08.25
-28.93%
17.08.25
17.08.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€706.60
05.08.24
05.08.24
€806.83
05.08.25
05.08.25
-6.30%
06.08.25
06.08.25